MultiversX
EGLD
Fundamental comparison between MultiversX and Injective
Not Financial Advice
This page is an informational analysis, not investment advice. The CryptoValue Score is an algorithmically generated rating from public data — it does not replace professional advice. Cryptocurrencies are highly volatile; total loss is possible. Read full risk disclaimer →
MultiversX
Coverage: 10/13 · 74%
Calculated:
Injective
Coverage: 10/13 · 74%
Calculated:
Detailed Comparison
| Metric | MultiversX | Injective |
|---|---|---|
| Price | $3.37 | $7.35 |
| Market Cap | $104.97M | $734.25M |
| 24h Volume | 1.7M | 77.1M |
| Rank | #264 | #87 |
| Circulating Supply | 31.1M | 100M |
| ATH | $545.64 | $52.62 |
MultiversX vs Injective — Analysis
Comparison of MultiversX and Injective: published market readings and a Value Score using up to 13 model components. Sourced project profiles add purpose, token role and risks where available.
Value Score Comparison
MultiversX: 75.1/100; Injective: 77.6/100. The difference is 2.5 score points with the same model, coverage and calculation timestamp.
Market Capitalization
Injective has 6.99 times the market capitalization of MultiversX. This ratio measures market size; it does not establish volatility or future returns.
Price Performance
Reported price change over 24 hours: MultiversX -0.23%, Injective 2.7%. Over 7 days: MultiversX 2.46%, Injective -8.57%. Missing readings are shown as —.
Distance from All-Time High
MultiversX trades at 0.62% of its reported all-time high; Injective at 13.97%. This distance describes price history and is not a standalone buy signal.
Conclusion
The readings show differences in market value and model assessment. Project purpose, token rights, risks, source dates and data coverage also matter. A higher score does not predict higher returns or lower risk.